Characteristics | TN-IBC | TN-non IBC | P value | ||||
---|---|---|---|---|---|---|---|
No. of patients (%) | No. of patients (%) | ||||||
Total number of patients | 39 | 49 | |||||
Age (years), median (min-max) | 49 (26-78) | 56 (28-77) | 0.1681 | ||||
Clinical stage of diagnosis | I | 9 | (19) | 8.904e-09 | |||
II | 17 | (35) | |||||
III | 27 | (69) | III | 18 | (36) | ||
IV | 5 | (13) | IV | 5 | (10) | ||
Unknown | 7 | (18) | Unknown | 0 | (0) | ||
Nuclear grade | I | 0 | (0) | I | 3 | (6) | 0.2048 |
II | 4 | (10) | II | 10 | (20) | ||
III | 33 | (85) | III | 35 | (72) | ||
Unknown | 2 | (5) | Unknown | 1 | (2) | ||
Tumor embolism | Positive | 24 | (62) | Positive | 3 | (6) | 3.604e-09 |
Negative | 12 | (30) | Negative | 20 | (41) | ||
Unknown | 2 | (8) | Unknown | 26 | (53) | ||
Neoadjuvant therapy (stages I-III) | Positive | 21 | (78) | Positive | 29 | (66) | 0.1684 |
Negative | 5 | (18) | Negative | 15 | (34) | ||
Unknown | 1 | (4) | Unknown | 0 | (0) |